Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model

10.18632/oncotarget.1596

Saved in:
Bibliographic Details
Main Authors: Siveen, K.S, Mustafa, N, Li, F, Kannaiyan, R, Ahn, K.S, Kumar, A.P, Chng, W.-J, Sethi, G
Other Authors: PHARMACOLOGY
Format: Article
Published: Impact Journals LLC 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/175000
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-175000
record_format dspace
spelling sg-nus-scholar.10635-1750002024-11-12T22:45:30Z Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model Siveen, K.S Mustafa, N Li, F Kannaiyan, R Ahn, K.S Kumar, A.P Chng, W.-J Sethi, G PHARMACOLOGY MEDICINE CANCER SCIENCE INSTITUTE OF SINGAPORE bortezomib caspase 3 chemokine receptor CXCR4 cyclooxygenase 2 doxorubicin gelatinase B immunoglobulin enhancer binding protein interleukin 6 Ki 67 antigen melphalan nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase protein bcl 2 syndecan 1 thymoquinone transcription factor RelA tumor necrosis factor alpha vasculotropin antineoplastic agent benzoquinone derivative boronic acid derivative bortezomib immunoglobulin enhancer binding protein pyrazine derivative thymoquinone animal experiment animal model animal tissue antineoplastic activity antiproliferative activity apoptosis article Bcl 2 gene cancer cell culture cancer inhibition cancer resistance cell isolation concentration response controlled study cox2 gene CXCR4 gene drug potentiation drug sensitivity enzyme activation gene disruption gene product human human cell IL 6 gene in vitro study in vivo study ki 67 gene male migration inhibition MMP9 gene mouse multiple myeloma myeloma cell nonhuman p65 gene protein cleavage protein expression TNFalpha gene tumor invasion tumor xenograft VEGF gene animal Bagg albino mouse cell proliferation disease model drug effects drug potentiation drug screening genetics metabolism multiple myeloma nude mouse pathology randomization signal transduction tumor cell line Animals Antineoplastic Combined Chemotherapy Protocols Apoptosis Benzoquinones Boronic Acids Cell Line, Tumor Cell Proliferation Disease Models, Animal Drug Synergism Humans Male Mice Mice, Inbred BALB C Mice, Nude Multiple Myeloma NF-kappa B Pyrazines Random Allocation Signal Transduction Xenograft Model Antitumor Assays 10.18632/oncotarget.1596 Oncotarget 5 3 634-648 2020-09-09T02:58:12Z 2020-09-09T02:58:12Z 2014 Article Siveen, K.S, Mustafa, N, Li, F, Kannaiyan, R, Ahn, K.S, Kumar, A.P, Chng, W.-J, Sethi, G (2014). Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model. Oncotarget 5 (3) : 634-648. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.1596 19492553 https://scholarbank.nus.edu.sg/handle/10635/175000 Impact Journals LLC Unpaywall 20200831
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic bortezomib
caspase 3
chemokine receptor CXCR4
cyclooxygenase 2
doxorubicin
gelatinase B
immunoglobulin enhancer binding protein
interleukin 6
Ki 67 antigen
melphalan
nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase
protein bcl 2
syndecan 1
thymoquinone
transcription factor RelA
tumor necrosis factor alpha
vasculotropin
antineoplastic agent
benzoquinone derivative
boronic acid derivative
bortezomib
immunoglobulin enhancer binding protein
pyrazine derivative
thymoquinone
animal experiment
animal model
animal tissue
antineoplastic activity
antiproliferative activity
apoptosis
article
Bcl 2 gene
cancer cell culture
cancer inhibition
cancer resistance
cell isolation
concentration response
controlled study
cox2 gene
CXCR4 gene
drug potentiation
drug sensitivity
enzyme activation
gene disruption
gene product
human
human cell
IL 6 gene
in vitro study
in vivo study
ki 67 gene
male
migration inhibition
MMP9 gene
mouse
multiple myeloma
myeloma cell
nonhuman
p65 gene
protein cleavage
protein expression
TNFalpha gene
tumor invasion
tumor xenograft
VEGF gene
animal
Bagg albino mouse
cell proliferation
disease model
drug effects
drug potentiation
drug screening
genetics
metabolism
multiple myeloma
nude mouse
pathology
randomization
signal transduction
tumor cell line
Animals
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Benzoquinones
Boronic Acids
Cell Line, Tumor
Cell Proliferation
Disease Models, Animal
Drug Synergism
Humans
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Multiple Myeloma
NF-kappa B
Pyrazines
Random Allocation
Signal Transduction
Xenograft Model Antitumor Assays
spellingShingle bortezomib
caspase 3
chemokine receptor CXCR4
cyclooxygenase 2
doxorubicin
gelatinase B
immunoglobulin enhancer binding protein
interleukin 6
Ki 67 antigen
melphalan
nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase
protein bcl 2
syndecan 1
thymoquinone
transcription factor RelA
tumor necrosis factor alpha
vasculotropin
antineoplastic agent
benzoquinone derivative
boronic acid derivative
bortezomib
immunoglobulin enhancer binding protein
pyrazine derivative
thymoquinone
animal experiment
animal model
animal tissue
antineoplastic activity
antiproliferative activity
apoptosis
article
Bcl 2 gene
cancer cell culture
cancer inhibition
cancer resistance
cell isolation
concentration response
controlled study
cox2 gene
CXCR4 gene
drug potentiation
drug sensitivity
enzyme activation
gene disruption
gene product
human
human cell
IL 6 gene
in vitro study
in vivo study
ki 67 gene
male
migration inhibition
MMP9 gene
mouse
multiple myeloma
myeloma cell
nonhuman
p65 gene
protein cleavage
protein expression
TNFalpha gene
tumor invasion
tumor xenograft
VEGF gene
animal
Bagg albino mouse
cell proliferation
disease model
drug effects
drug potentiation
drug screening
genetics
metabolism
multiple myeloma
nude mouse
pathology
randomization
signal transduction
tumor cell line
Animals
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Benzoquinones
Boronic Acids
Cell Line, Tumor
Cell Proliferation
Disease Models, Animal
Drug Synergism
Humans
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Multiple Myeloma
NF-kappa B
Pyrazines
Random Allocation
Signal Transduction
Xenograft Model Antitumor Assays
Siveen, K.S
Mustafa, N
Li, F
Kannaiyan, R
Ahn, K.S
Kumar, A.P
Chng, W.-J
Sethi, G
Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model
description 10.18632/oncotarget.1596
author2 PHARMACOLOGY
author_facet PHARMACOLOGY
Siveen, K.S
Mustafa, N
Li, F
Kannaiyan, R
Ahn, K.S
Kumar, A.P
Chng, W.-J
Sethi, G
format Article
author Siveen, K.S
Mustafa, N
Li, F
Kannaiyan, R
Ahn, K.S
Kumar, A.P
Chng, W.-J
Sethi, G
author_sort Siveen, K.S
title Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model
title_short Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model
title_full Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model
title_fullStr Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model
title_full_unstemmed Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse model
title_sort thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of nf-?b regulated gene products in multiple myeloma xenograft mouse model
publisher Impact Journals LLC
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/175000
_version_ 1821218164895121408